Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF286B | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | ATP6V0E1 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
mRNA | ANAPC13 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
mRNA | ANO8 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | TMSB15B | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | ZCCHC11 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | TP53 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | MATR3 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | RP5-1028K7.3 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | NINL | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |